05/29/18 Opioid Receptor Agonist Market Pipeline Therapeutics 2018 Top Key Players

Opioid Receptor Agonist Market Pipeline Review provides comprehensive information on the therapeutics under development and growth prospect for Opioid Receptor Agonist Market.

May 29, 2018

Bridge Therapeutics was named one of the key players of the opioid receptor agonist market of therapeutics in developmental phase by Journal Healthcare. Buprenorphine, a partial agonist of the Mu opioid receptor (MOR) gives it advantages over traditional, full agonist opioids in that it is less addictive and safer. The therapeutic market for Mu agonist opioids are typically related to pain relief and opioid addiction.

Journal Healthcare offers news and resources to the public and features news and resources focused on all areas of healthcare including diseases, medicines, fitness, among others.

Read the full article Here

For more information about Bridge Therapeutics please contact us today using the form below.